195 related articles for article (PubMed ID: 32640966)
1. Quantitative Characterization of Phenotypical Markers After Differentiation of SH-SY5Y Cells.
Ducray AD; Wiedmer L; Herren F; Widmer HR; Mevissen M
CNS Neurol Disord Drug Targets; 2020; 19(8):618-629. PubMed ID: 32640966
[TBL] [Abstract][Full Text] [Related]
2. Silica nanoparticle-exposure during neuronal differentiation modulates dopaminergic and cholinergic phenotypes in SH-SY5Y cells.
Wiedmer L; Ducray AD; Frenz M; Stoffel MH; Widmer HR; Mevissen M
J Nanobiotechnology; 2019 Apr; 17(1):46. PubMed ID: 30935413
[TBL] [Abstract][Full Text] [Related]
3. Influence of serum concentration in retinoic acid and phorbol ester induced differentiation of SH-SY5Y human neuroblastoma cell line.
Magalingam KB; Radhakrishnan AK; Somanath SD; Md S; Haleagrahara N
Mol Biol Rep; 2020 Nov; 47(11):8775-8788. PubMed ID: 33098048
[TBL] [Abstract][Full Text] [Related]
4. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease.
Xie HR; Hu LS; Li GY
Chin Med J (Engl); 2010 Apr; 123(8):1086-92. PubMed ID: 20497720
[TBL] [Abstract][Full Text] [Related]
5. Estrogen-related receptor gamma regulates dopaminergic neuronal phenotype by activating GSK3β/NFAT signaling in SH-SY5Y cells.
Lim J; Choi HS; Choi HJ
J Neurochem; 2015 May; 133(4):544-57. PubMed ID: 25727910
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease cybrids, differentiated or undifferentiated, maintain morphological and biochemical phenotypes different from those of control cybrids.
Appukuttan TA; Ali N; Varghese M; Singh A; Tripathy D; Padmakumar M; Gangopadhyay PK; Mohanakumar KP
J Neurosci Res; 2013 Jul; 91(7):963-70. PubMed ID: 23653325
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Effects of 3,4-Catechol-PV (One Major MDPV Metabolite) on Human Dopaminergic SH-SY5Y Cells.
Coccini T; Vecchio S; Crevani M; De Simone U
Neurotox Res; 2019 Jan; 35(1):49-62. PubMed ID: 29934755
[TBL] [Abstract][Full Text] [Related]
8. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer's Disease Studies.
de Medeiros LM; De Bastiani MA; Rico EP; Schonhofen P; Pfaffenseller B; Wollenhaupt-Aguiar B; Grun L; Barbé-Tuana F; Zimmer ER; Castro MAA; Parsons RB; Klamt F
Mol Neurobiol; 2019 Nov; 56(11):7355-7367. PubMed ID: 31037648
[TBL] [Abstract][Full Text] [Related]
10. New insights on Parkinson's disease from differentiation of SH-SY5Y into dopaminergic neurons: An involvement of aquaporin4 and 9.
Avola R; Graziano ACE; Pannuzzo G; Albouchi F; Cardile V
Mol Cell Neurosci; 2018 Apr; 88():212-221. PubMed ID: 29428877
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of proliferative and differentiated SH-SY5Y cell line as a model for Parkinson's disease.
Alrashidi H; Eaton S; Heales S
Neurochem Int; 2021 May; 145():105009. PubMed ID: 33684546
[TBL] [Abstract][Full Text] [Related]
12. Changes in Cell Cycle and Up-Regulation of Neuronal Markers During SH-SY5Y Neurodifferentiation by Retinoic Acid are Mediated by Reactive Species Production and Oxidative Stress.
Kunzler A; Zeidán-Chuliá F; Gasparotto J; Girardi CS; Klafke K; Petiz LL; Bortolin RC; Rostirolla DC; Zanotto-Filho A; de Bittencourt Pasquali MA; Dickson P; Dunkley P; Moreira JCF; Gelain DP
Mol Neurobiol; 2017 Nov; 54(9):6903-6916. PubMed ID: 27771902
[TBL] [Abstract][Full Text] [Related]
13. Differentiating SH-SY5Y Cells into Polarized Human Neurons for Studying Endogenous and Exogenous Tau Trafficking: Four Protocols to Obtain Neurons with Noradrenergic, Dopaminergic, and Cholinergic Properties.
Langerscheidt F; Bell-Simons M; Zempel H
Methods Mol Biol; 2024; 2754():521-532. PubMed ID: 38512687
[TBL] [Abstract][Full Text] [Related]
14. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
[TBL] [Abstract][Full Text] [Related]
15. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
[TBL] [Abstract][Full Text] [Related]
16. The Neuroprotective Role of Insulin Against MPP(+) -Induced Parkinson's Disease in Differentiated SH-SY5Y Cells.
Ramalingam M; Kim SJ
J Cell Biochem; 2016 Apr; 117(4):917-26. PubMed ID: 26364587
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling.
Korecka JA; van Kesteren RE; Blaas E; Spitzer SO; Kamstra JH; Smit AB; Swaab DF; Verhaagen J; Bossers K
PLoS One; 2013; 8(5):e63862. PubMed ID: 23724009
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
19. TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C; Ambrosio S; Ventura F; Ferrer I; Reiriz J
Brain Res; 2002 Dec; 958(1):152-60. PubMed ID: 12468040
[TBL] [Abstract][Full Text] [Related]
20. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
Kovalevich J; Santerre M; Langford D
Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
